Showing results (221-230 of 325) with videos related to
Sort By:
Pageof 33
Journal of Human Hypertension|June 26, 2002
Oxidative stress in malignant and non-malignant phase hypertensionG Y H Lip, E Edmunds, S L Nuttall, et al.Journal of Neurosurgery|June 1, 1986
Reduced platelet function in subarachnoid hemorrhageS A Tsementzis, J S Gill, E R Hitchcock, et al.Journal of Human Hypertension|September 17, 2004
The financial cost of optimising blood pressure controlT Shiner, L Simons, H Parkinson, et al.Circulation|August 1, 1996
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirinG Y Lip, P L Lip, J Zarifis, et al.QJM : Monthly Journal of the Association of Physicians|June 8, 2001
Dyslipidaemia in patients with malignant-phase hypertensionE Edmunds, M J Landray, F L Li-Saw-Hee, et al.Canadian Journal of Physiology and Pharmacology|January 1, 1989
Effect of catecholamine-induced cardiac hypertrophy on the force-interval relationshipP B Taylor, R K Helbing, S Rourke, et al.The Quarterly Journal of Medicine|July 1, 1976
Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronismD G Beevers, J J Brown, J B Ferriss, et al.Journal of Internal Medicine|December 23, 2003
Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)C G C Spencer, D Gurney, D C Felmeden, et al.International Journal of Legal Medicine|March 31, 2016
Effects of the Ion PGM™ Hi-Q™ sequencing chemistry on sequence data qualityJennifer D Churchill, Jonathan L King, Ranajit Chakraborty, et al.International Journal of Legal Medicine|February 23, 2018
Massively parallel sequencing-enabled mixture analysis of mitochondrial DNA samplesJennifer D Churchill, Monika Stoljarova, Jonathan L King, et al.Pageof 33